Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety

Trial Profile

Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2017

At a glance

  • Drugs Metronidazole (Primary)
  • Indications Infections; Vaginal diseases
  • Focus Registrational; Therapeutic Use
  • Acronyms SMART GIVES
  • Sponsors Curatek Pharmaceuticals
  • Most Recent Events

    • 18 Jul 2017 Status changed from active, no longer recruiting to completed.
    • 24 May 2017 Planned End Date changed from 1 Apr 2017 to 1 Jun 2017.
    • 24 May 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top